Price (delayed)
$4.995
Market cap
$315.25M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.04
Enterprise value
$478.95M
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a
There are no recent dividends present for CDMO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.